长期生存-话题@MedSci - 梅斯（MedSci）

#长期生存#

69篇内容 | 2178人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2183377, encodeId=6e0721833e7a2, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a> <a href='/topic/show?id=76a83086442' target=_blank style='color:#2F92EE;'>#冠状动脉搭桥#</a> <a href='/topic/show?id=236e110434c4' target=_blank style='color:#2F92EE;'>#高脂蛋白（a）#</a>, objectTitle=JAHA：高脂蛋白(a)对冠状动脉搭桥患者术后长期生存的影响, objectType=article, longId=810549, objectId=64ea81054985, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240122/1705924628161_1739456.jpg, objectUrl=/article/show_article.do?id=64ea81054985, replyNumber=0, likeNumber=69, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=64ea81054985, moduleTitle=JAHA：高脂蛋白(a)对冠状动脉搭桥患者术后长期生存的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=64ea81054985)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1618352, encodeId=670b1618352bd, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率, objectType=article, longId=733151, objectId=329ee33151fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=329ee33151fa, replyNumber=0, likeNumber=84, createdTime=2022-07-26, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=329ee33151fa, moduleTitle=CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=329ee33151fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618351, encodeId=73fe161835116, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Eur J Heart Fail：急性心力衰竭住院后的长期生存和预期寿命, objectType=article, longId=731087, objectId=6afee310878f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6afee310878f, replyNumber=0, likeNumber=70, createdTime=2022-07-03, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6afee310878f, moduleTitle=Eur J Heart Fail：急性心力衰竭住院后的长期生存和预期寿命, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6afee310878f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618350, encodeId=05d2161835098, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Crit Care：临床脆弱量表和医院脆弱风险评分预测危重患者长期生存能力的比较, objectType=article, longId=726775, objectId=8911e267753f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8911e267753f, replyNumber=0, likeNumber=76, createdTime=2022-05-14, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8911e267753f, moduleTitle=Crit Care：临床脆弱量表和医院脆弱风险评分预测危重患者长期生存能力的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8911e267753f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618349, encodeId=ee9b161834990, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Neurology：影响WHO II级脑胶质瘤术后妊娠妇女长期生存的因素, objectType=article, longId=725413, objectId=7b0fe2541313, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b0fe2541313, replyNumber=0, likeNumber=75, createdTime=2022-04-27, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b0fe2541313, moduleTitle=Neurology：影响WHO II级脑胶质瘤术后妊娠妇女长期生存的因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7b0fe2541313)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618348, encodeId=a08a1618348f3, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, objectType=article, longId=724357, objectId=fc10e2435740, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc10e2435740, replyNumber=0, likeNumber=77, createdTime=2022-04-17, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc10e2435740, moduleTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fc10e2435740)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618347, encodeId=a24a161834e62, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, objectType=article, longId=301037, objectId=1d0d30103eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0d30103eaf, replyNumber=0, likeNumber=75, createdTime=2022-03-19, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0d30103eaf, moduleTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1d0d30103eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618346, encodeId=2c6b1618346db, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率, objectType=article, longId=300192, objectId=89be30019253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89be30019253, replyNumber=0, likeNumber=73, createdTime=2022-03-08, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89be30019253, moduleTitle=Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=89be30019253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618345, encodeId=a40d1618345a8, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Gastric Cancer: 阿司匹林与胃腺癌术后长期生存的关系, objectType=article, longId=299214, objectId=288a29921474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=288a29921474, replyNumber=0, likeNumber=69, createdTime=2022-02-21, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=288a29921474, moduleTitle=Gastric Cancer: 阿司匹林与胃腺癌术后长期生存的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=288a29921474)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618344, encodeId=7f4b1618344cd, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=JAHA：疾病特异性健康状况与外周动脉疾病患者长期生存之间的关系, objectType=article, longId=295379, objectId=d3162953e91d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3162953e91d, replyNumber=0, likeNumber=71, createdTime=2022-02-11, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3162953e91d, moduleTitle=JAHA：疾病特异性健康状况与外周动脉疾病患者长期生存之间的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d3162953e91d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618343, encodeId=2ce7161834372, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Thorac Cancer：回顾性分析使用nivolumab治疗获得长期生存的NSCLC患者的相关因素, objectType=article, longId=293621, objectId=07a32936217f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07a32936217f, replyNumber=0, likeNumber=74, createdTime=2022-01-10, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07a32936217f, moduleTitle=Thorac Cancer：回顾性分析使用nivolumab治疗获得长期生存的NSCLC患者的相关因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=07a32936217f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618342, encodeId=7960161834284, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Gastrointest Endosc：早期胃癌老年患者采用内镜切除治疗后的长期生存率, objectType=article, longId=293481, objectId=d2a129348145, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2a129348145, replyNumber=0, likeNumber=0, createdTime=2022-01-07, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2a129348145, moduleTitle=Gastrointest Endosc：早期胃癌老年患者采用内镜切除治疗后的长期生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d2a129348145)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618341, encodeId=90001618341e9, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Circ-Heart Fail：Tafamidis对甲状腺素运载蛋白淀粉样变心肌病患者长期生存的疗效, objectType=article, longId=292793, objectId=a401292e93ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a401292e93ad, replyNumber=0, likeNumber=73, createdTime=2021-12-28, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a401292e93ad, moduleTitle=Circ-Heart Fail：Tafamidis对甲状腺素运载蛋白淀粉样变心肌病患者长期生存的疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a401292e93ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618340, encodeId=99371618340d2, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Front Oncol：PD-1抑制剂nivolumab（纳武利尤单抗）治疗NSCLC患者的长期生存疗效和血液学标志物的探索, objectType=article, longId=291839, objectId=14f2291839cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14f2291839cd, replyNumber=0, likeNumber=69, createdTime=2021-12-16, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14f2291839cd, moduleTitle=Front Oncol：PD-1抑制剂nivolumab（纳武利尤单抗）治疗NSCLC患者的长期生存疗效和血液学标志物的探索, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=14f2291839cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618339, encodeId=38071618339a6, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率, objectType=article, longId=221742, objectId=0372221e4226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0372221e4226, replyNumber=0, likeNumber=82, createdTime=2021-12-10, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0372221e4226, moduleTitle=Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0372221e4226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618338, encodeId=e9341618338bb, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Front Oncol：胃MALT淋巴瘤的长期生存结局:来自韩国的多中心研究结果, objectType=article, longId=218721, objectId=43ac218e212a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ac218e212a, replyNumber=0, likeNumber=75, createdTime=2021-10-18, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ac218e212a, moduleTitle=Front Oncol：胃MALT淋巴瘤的长期生存结局:来自韩国的多中心研究结果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=43ac218e212a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618337, encodeId=09d3161833e75, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=AJRCCM：肺动脉高压初始治疗策略与长期生存的关系, objectType=article, longId=218014, objectId=09bf218014d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09bf218014d3, replyNumber=0, likeNumber=87, createdTime=2021-10-02, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09bf218014d3, moduleTitle=AJRCCM：肺动脉高压初始治疗策略与长期生存的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=09bf218014d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618336, encodeId=59c61618336b0, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Stroke：脑出血后的长期生存、死亡原因和5年死亡率趋势, objectType=article, longId=217057, objectId=44c721e05738, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44c721e05738, replyNumber=0, likeNumber=77, createdTime=2021-09-15, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44c721e05738, moduleTitle=Stroke：脑出血后的长期生存、死亡原因和5年死亡率趋势, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=44c721e05738)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618335, encodeId=1b8c161833554, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=Blood：预测接受强化化疗的AML老年患者长期生存预后的新模型！, objectType=article, longId=216313, objectId=d2db2163135b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2db2163135b, replyNumber=0, likeNumber=90, createdTime=2021-08-27, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2db2163135b, moduleTitle=Blood：预测接受强化化疗的AML老年患者长期生存预后的新模型！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d2db2163135b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1618334, encodeId=0f6e161833488, content=<a href='/topic/show?id=3ebc9e0210b' target=_blank style='color:#2F92EE;'>#长期生存#</a>, objectTitle=新研究评估Masimo SedLine®脑功能监护仪能否预测心跳骤停后ICU患者的神经系统转归和长期生存, objectType=article, longId=213888, objectId=d47f213888ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d47f213888ab, replyNumber=0, likeNumber=71, createdTime=2021-07-09, rootId=0, userName=luckyshitiancai_42705690, userId=e1f719885829, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d47f213888ab, moduleTitle=新研究评估Masimo SedLine®脑功能监护仪能否预测心跳骤停后ICU患者的神经系统转归和长期生存, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d47f213888ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

长期生存

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#长期生存# #冠状动脉搭桥# #高脂蛋白（a）#

JAHA：高脂蛋白(a)对冠状动脉搭桥患者术后长期生存的影响

2024-01-23发表于上海

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率

2022-07-26

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Eur J Heart Fail：急性心力衰竭住院后的长期生存和预期寿命

2022-07-03

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Crit Care：临床脆弱量表和医院脆弱风险评分预测危重患者长期生存能力的比较

2022-05-14

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Neurology：影响WHO II级脑胶质瘤术后妊娠妇女长期生存的因素

2022-04-27

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Stroke：急性卒中后的长期生存率、卒中复发和预期寿命

2022-04-17

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期

2022-03-19

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Gastric Cancer:低剂量阿司匹林不会延长胃腺癌除术后患者的长期生存率

2022-03-08

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Gastric Cancer: 阿司匹林与胃腺癌术后长期生存的关系

2022-02-21

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

JAHA：疾病特异性健康状况与外周动脉疾病患者长期生存之间的关系

2022-02-11

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Thorac Cancer：回顾性分析使用nivolumab治疗获得长期生存的NSCLC患者的相关因素

2022-01-10

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Gastrointest Endosc：早期胃癌老年患者采用内镜切除治疗后的长期生存率

2022-01-07

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Circ-Heart Fail：Tafamidis对甲状腺素运载蛋白淀粉样变心肌病患者长期生存的疗效

2021-12-28

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Front Oncol：PD-1抑制剂nivolumab（纳武利尤单抗）治疗NSCLC患者的长期生存疗效和血液学标志物的探索

2021-12-16

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Leukemia：70 岁及以上 AML 患者强化化疗或低甲基化药物后的长期生存率

2021-12-10

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Front Oncol：胃MALT淋巴瘤的长期生存结局:来自韩国的多中心研究结果

2021-10-18

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

AJRCCM：肺动脉高压初始治疗策略与长期生存的关系

2021-10-02

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Stroke：脑出血后的长期生存、死亡原因和5年死亡率趋势

2021-09-15

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

Blood：预测接受强化化疗的AML老年患者长期生存预后的新模型！

2021-08-27

luckyshitiancai_42705690 (审核中...)

前往app查看评论内容

#长期生存#

新研究评估Masimo SedLine®脑功能监护仪能否预测心跳骤停后ICU患者的神经系统转归和长期生存

2021-07-09

科室
- - 订阅+
  - 更多科室
工具
服务